The Prevalence of Hepatitis B and C among the Passively Screened Population and Blood Donors in Haryana, India: A Retrospective Analysis

VIEWS - 217 (Abstract) 51 (PDF)
Parveen Malhotra, Vani Malhotra, Usha Gupta, Paramjeet Singh Gill, Pushkar Pushkar, Yogesh Sanwariya

Abstract


Background. Hepatitis B and C are significant problems in India, especially in certain hotspots such as Haryana state. Since the data derived from the large-scale studies are unavailable, reports from individual centers or blood bank data are largely relied on to get a glimpse of the prevalence rate in India. This retrospective study aims to estimate the prevalence of hepatitis B and C based on the data collected from blood banks and passive screening of patients at PGIMS, Rohtak.

Methods. The first half of the dataset which contains routine hepatitis B and C test results was derived from blood banks. The other half of dataset was derived from the passive screening of patients from various outpatient departments and inpatient wards. The samples collected during the passive screening were tested for the positivity for HBsAg or anti-HCV antibody using ELISA tests.

Results. Analysis of the blood bank data revealed that the prevalence rates of HBsAg and anti-HCV antibody positivity were 0.80% and 0.81%, respectively, whereas the rates of the same derived from passive screening data were 5.23% and 5.18%, respectively.

Conclusion. The blood bank data did not depict the exact prevalence of hepatitis B and C. Concerns remain as they could possibly underestimate the rates. As opposed to that, the prevalence rates of passive screening data might possibly resemble to the genuine prevalence. Although it is sometimes inevitable to rely on blood bank data due to data paucity, cautiousness must be exercised when it comes to using this kind of data.


Keywords


Hepatitis B, Hepatitis C, HBsAg, Anti-HCV antibody, Blood banks, Passive screening

Full Text:

Download PDF

References


World Health Organization, 2015, Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. World Health Organization, Geneva.

World Health Organization, 2016, Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection, Updated Version. World Health Organization, Geneva.

World Health Organization, 2016, WHO Global Disease Estimates 2016. World Health Organization, Geneva.

Central Bureau of Health Intelligence, Ministry of Health and Family Welfare, 2016, National Health Profile. Central Bureau of Health Intelligence, Ministry of Health and Family Welfare, New Delhi.

World Health Organization, 2016, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. World Health Organization, Geneva.

Ott JJ, Stevens GA, Groeger J, et al., 2012, Global Epidemiology of Hepatitis B Virus Infection: New Estimates of Age-specific HbsAg Seroprevalence and Endemicity. Vaccine, 30(12):2212–9. DOI: 10.1016/j. vaccine.2011.12.116.

Abraham P, 2012, Viral Hepatitis in India. Clin Lab Med, 32(2):159–174.

Thyagarajan SP, Jayaram S, Mohanavalli B, 1996, Prevalence of HBV in General population of India. In: Sarin SK, Singal AK, editors. Hepatitis B in India: Problems and Prevention. CBS Publishers and Distributors, New Delhi, India, p5–16.

Lamontagne RJ, Bagga S, Bouchard MJ, et al., 2016, Hepatitis B Virus Molecular Biology and Pathogenesis. Hepatoma Res, 2(7):163. DOI: 10.20517/2394- 5079.2016.05.

Lavanchy D, 2004, Hepatitis B Virus Epidemiology, Disease Burden, Treatment, Arid Current and Emerging Prevention and Control Measures. J Viral Hepat, 11(2):97–107. DOI: 10.1046/j.1365-2893.2003.00487.x.

McMahon BJ, 2004, The Natural History of Chronic Hepatitis B Virus Infection. Semin Liver Dis, 24(1):17–21. DOI: 10.1055/s-2004-828674.

Hoofnagle JH, Doo E, Liang TJ, et al., 2007, Management of Hepatitis B: Summary of a Clinical Research Workshop. Hepatology, 45(4):1056–75. DOI: 10.1002/hep.21627.

Lok AS, McMahon BJ, 2007, Chronic Hepatitis B. Hepatology, 45(2):507–39.

Ganem D, Prince AM, 2004, Hepatitis B Virus Infection-natural History and Clinical Consequences. N Engl J Med, 350(11):1118–29. DOI: 10.1056/nejmra031087.

Fattovich G, 2003, Natural History and Prognosis of Hepatitis B. Semin Liver Dis, 23(1):47–58.

Fattovich G, Stroffolini T, Zagni I, et al., 2004, Hepatocellular Carcinoma in Cirrhosis: Incidence and Risk Factors. Gastroenterology, 127:S35–50. DOI: 10.1053/j. gastro.2004.09.014.

Malhotra P, Gupta U, Kamboj SB, et al., 2019, Jeevanrekha- Haryana Model For Treatment and Eliminating Hepatitis C. J Hematol Res, 6:32–4. DOI: 10.12974/2312-5411.2019.06.5.

Ray SC, Thomas DL. Hepatitis C. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Saunders, Philadelphia, PA, Pennsylvania, p1904–27. DOI: 10.1016/b978-1-4557-4801-3.00156-9.

Mysorekar VV, Rao SG, Mahadeva KC, 2008, Liver Histology in Patients on Hemodialysis with Chronic Hepatitis C Viral Infection. Indian J Pathol Microbiol, 51(2): 182–5. DOI: 10.4103/0377-4929.41648.

Ali S, Shukla I, Malik A, et al., 2008, Prevalence of HCV and HBV Infection in Liver Disorders in the Aligarh Region of Western Uttar Pradesh. Indian J Pathol Microbiol, 51(3):460–1. DOI: 10.4103/0377-4929.42540.

Narayanasamy K, Annasamy C, Ramalingam S, et al., 2015, Study of Hepatitis B and C Virus Infection in Urban and Rural Population of Tamil Nadu, India. Int J Curr Microbiol App Sci, 4(6):443-51.

Tandon BN, Acharya SK, Tandon A, et al., 1996, Epidemiology of Hepatitis B Virus Infection in India. Gut, 38(2):56–9. DOI: 10.1136/gut.38.suppl_2.s56.

Kurien T, Thyagarajan SP, Jeyaseelan L, et al., 2005, Community Prevalence of Hepatitis B Infection and Modes of Transmission in Tamil Nadu, India. Indian J Med Res, 121(5):670–5.

Chowdhury A, Santra A, Chakravorty R, et al., 2005, Community-based Epidemiology of Hepatitis B Virus Infection in West Bengal, India: Prevalence of Hepatitis B e Antigennegative Infection and Associated Viral Variants. J Gastroenterol Hepatol, 20(11):1712–20. DOI: 10.1111/j.1440-1746.2005.04070.x.

Ashraf H, Alam NH, Rothermundt C, et al., 2010, Prevalence and Risk Factors of Hepatitis B and C Virus Infections in an Impoverished Urban Community in Dhaka, Bangladesh. BMC Infect Dis, 10:208. DOI: 10.1186/1471-2334-10-208.

Behal R, Jain R, Behal KK, et al., 2008, Seroprevalence and Risk Factors for Hepatitis B Virus Infection Among General Population in Northern India. Arq Gastroenterol, 45(2):137–40. DOI: 10.1590/s0004-28032008000200009.

Saeed U, Waheed Y, Ashraf M, et al., 2014, Hepatitis B and Hepatitis C Viruses: A Review of Viral Genomes, Viral Induced Host Immune Responses, Genotypic Distributions and Worldwide Epidemiology. Asian Pac J Trop Dis, 4(2):88–96. DOI: 10.1016/s2222-1808(14)60322-4.

Gowri V, Chandraleka C, Vanaja R, et al., 2012, The Current Seroprevalence of Hepatitis C Virus in a Tertiary Care Centre in Vellore, Tamil Nadu. Indian J Commun Med, 37(2):137. DOI: 10.4103/0970-0218.96110.

Chowdhury A, Santra A, Chaudhuri S, et al., 2003, Hepatitis C Virus Infection in the General Population: A Community-based Study in West Bengal, India. Hepatology, 37(4):802–9. DOI: 10.1053/jhep.2003.50157.

Khaja MN, Madhavi C, Thippavazzula R, et al., 2006, High Prevalence of Hepatitis C Virus Infection and Genotype Distribution Among General Population, Blood Donors and Risk Groups. Infect Genet Evol, 6(3):198–204. DOI: 10.1016/j.meegid.2005.04.001.

Phukan AC, Sharma SK, Das HK, et al., 2001, HCV Activity in an Isolated Community in North East India. Indian J Pathol Microbiol, 44(4):403–405.




DOI: http://dx.doi.org/10.18063/ghl.v2i2.256

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Malhotra, et al.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Recent Articles | About Journal | For Author | Fees | About Whioce

Copyright © Whioce Publishing Pte Ltd. All Rights Reserved.